Identification | Back Directory | [Name]
1,3,5[10]-ESTRATRIENE-3,16ALPHA-DIOL-17-ONE | [CAS]
566-76-7 | [Synonyms]
C05300 16α-OHE1 16A-hydroxyestrone Estriol Impurity H 16α-hydroxy Estrone Hydroxyestrone, 16α- Estriol EP Impurity H 16ALPHA-HYDROXYESTRONE 16ALPHA-HYDROXYESTERONE 16α-Hydroxyestrone (solution) Conjugated Estrogens EP Impurity H 16α-Hydroxyestrone Solution, 100ppm 16α-Hydroxyestrone Solution, 100ppm 1,3,5(10)-Estratriene-3,16α-diol-17-one Estra-1,3,5(10)-triene-3,16α-diol-17-one Estra-1,3,5(10)-triene-3,16a-diol-17-one Estriol Impurity 8 (Estriol EP Impurity H) 3,16a-Dihydroxy-1,3,5(10)-estratrien-17-one 1,3,5[10]-ESTRATRIENE-3,16ALPHA-DIOL-17-ONE 1,3,5(10)-ESTRATRIEN-3,16-ALPHA-DIOL-17-ONE 3,16α-Dihydroxy-1,3,5(10)-estratrien-17-one 3,16ALPHA-DIHYDROXY-1,3,5[10]-ESTRATRIEN-17-ONE (16a)-3,16-Dihydroxyestra-1,3,5(10)-trien-17-one (16α)-3,16-Dihydroxyestra-1,3,5(10)-trien-17-one (16R)-3,16α-Dihydroxy-1,3,5(10)-estratriene-17-one Estra-1,3,5(10)-trien-17-one, 3,16-dihydroxy-, (16α)- (8R,9S,13S,14S,16R)-3,16-dihydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one (8R,9S,13S,14S,16R)-3,16-Dihydroxy-13-methyl-7,8,9,11,12,13,15,16-octahydro-6H-cyclopenta[a]phenanthren-17(14H)-one | [Molecular Formula]
C18H22O3 | [MDL Number]
MFCD00870436 | [MOL File]
566-76-7.mol | [Molecular Weight]
286.37 |
Chemical Properties | Back Directory | [Melting point ]
209-211°C | [Boiling point ]
493.2±45.0 °C(Predicted) | [density ]
1.249±0.06 g/cm3(Predicted) | [storage temp. ]
-20°C Freezer | [solubility ]
DMSO (Slightly), Ethanol (Slightly), Methanol (Slightly) | [form ]
Solid | [pka]
10.23±0.60(Predicted) | [color ]
White to Light Beige |
Hazard Information | Back Directory | [Description]
The naturally-occurring estrogens are estrone (E1, ), estradiol (E2, ), and estriol (E3, ). 16α-hydroxy Estrone (16α-OHE1) is a hydroxylated metabolite of E1 as well as an interconversion product with E2. E1 is 16α-hydroxylated by cytochrome P450 (CYP) isoforms, including CYP1A1, CYP3A5, CYP3A4, and CYP3A7, with CYP3A5 being breast-specific. 16α-OHE1 is sulphatized or glucuronidated before excretion. It is increased in rheumatoid arthritis and decreased by physical activity. Unlike the parent estrogens and other hydroxylated metabolites of E1, 16α-OHE1 binds covalently and persistently activates estrogen receptors. In addition, this metabolite increases cell proliferation and does not suppress TNF-α secretion, whereas other estrogen metabolites are not pro-proliferative and have marked effects on TNF-α secretion. The levels of 16α-OHE1 are increased in some forms of hormone therapy. Because hormone therapy increases breast cancer risk, 16α-OHE1 has been implicated as a risk factor for breast cancer, although supportive data remains elusive. | [Chemical Properties]
Pale Pink Solid | [Uses]
16α-Hydroxy Estrone (Estriol EP Impurity H) is a major metabolite of Estradiol. | [Uses]
A major metabolite of Estradiol | [Definition]
ChEBI: The 16alpha-hydroxy derivative of estrone; a minor estrogen metabolite. |
|
|